Adipose Stem Cell Secretion Dosing for Sustained Hair and Skin Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for hair growth and wound healing, such as those using adipose-derived stem cell secretions, do not provide sustained effects after the treatment period, and there is a need for improved methods to enhance scalp and skin quality.
Innovation Solution
A pharmaceutical composition comprising adipose stem cell secretions (ASC-CM) is administered intradermally or subcutaneously at a specific dose of 0.3 to 0.6 µg of protein abundance per cm² of scalp or skin to promote tissue regeneration, rejuvenation, and hair modification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If adipose-derived stem cell secretion is administered for hair growth treatment, then hair increasing effect is achieved during treatment period, but the effect disappears when treatment is ended
Solution Approach 1:
The patent changes the dosage parameter by specifying a precise range of 0.3 to 0.6 µg of protein abundance per cm², which optimizes the treatment to achieve sustained hair growth effects that persist after treatment completion, resolving the contradiction between achieving hair growth during treatment and maintaining the effect afterward
2Reliability
If adipose-derived stem cell secretion is administered at higher doses, then wound healing effect is enhanced, but the cost and complexity of treatment increases
Solution Approach 1:
The patent optimizes the dosage parameter to a specific range of 0.3 to 0.6 µg of protein abundance per cm², which achieves effective wound healing without requiring excessively high doses that would increase treatment complexity and cost, thus resolving the contradiction between healing effectiveness and treatment simplicity
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides a pharmaceutical composition for use in modifying scalp or skin, promoting wound healing, or modifying hair, comprising a secretion from adipose stem cells as an active ingredient, wherein 0.3 to 0.6 µg of the secretion in terms of protein abundance per site in scalp or skin is administered.